Affiliation:
1. Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto: Universidade de Sao Paulo Faculdade de Medicina de Ribeirao Preto
2. Universidade de Sao Paulo Faculdade de Medicina de Ribeirao Preto
Abstract
Abstract
Purpose
The COVID-19 pandemic has impacted the management of several diseases. Our goal was to assess the outcomes of women diagnosed with relapsed breast cancer during the pandemic period.
Methods
We evaluated a cohort of 187 women with breast cancer recurrence out of a total of 2,891 patients diagnosed with breast cancer between January 2011 and March 2022.
Results
At the time of recurrence diagnosis, 116 patients (62%) had distant metastasis and 71 (38%) had local recurrence. Of the women with initial local recurrence, 28% (35) died, while 72% (91) of the women with distant recurrence died. The pandemic group showed a significant decrease in overall survival (OS) compared to the pre-pandemic group (median 9 months versus 22 months, respectively; HR: 1.92; 95% CI: 1.19–3.12).
Conclusion
The pandemic had a negative impact on the survival of patients with breast cancer recurrence.
Publisher
Research Square Platform LLC
Reference17 articles.
1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou F;Lancet,2020
2. COVID-19: towards controlling of a pandemic;Bedford J;Lancet,2020
3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang W;Lancet Oncol,2020
4. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay J;Int J Cancer,2019
5. Instituto Nacional do Câncer (2019) Estimativa 2020: incidência do Câncer no Brasil. https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2020-incidencia-de-cancer-no-brasil.pdf. Accessed 20 Oct 2022